Thorell Marella
Insider CIK 1826323 · CARM Director · MCRB See Remarks · EPIX Director · EVLO Chief Financial Officer · VLON Director · CNTA Chief Accounting Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| MCRB Seres Therapeutics, Inc. | A Award deriv | 2026-07-08 | 2026-07-10 | 7,500 | — | $0 | 7,500 | SEC↗ |
| MCRB Seres Therapeutics, Inc. | A Award deriv | 2026-03-04 | 2026-03-06 | 22,500 | — | $0 | 22,500 | SEC↗ |
| EPIX ESSA Pharma Inc. | D To issuer | 2025-10-09 | 2025-10-15 | 2,881 | — | $0 | 0 | SEC↗ |
| MCRB Seres Therapeutics, Inc. | A Award deriv | 2025-02-07 | 2025-02-11 | 650,000 | — | $0 | 650,000 | SEC↗ |
| CARM Carisma Therapeutics Inc. | A Award deriv | 2024-07-01 | 2024-07-01 | 38,700 | — | $0 | 38,700 | SEC↗ |
| MCRB Seres Therapeutics, Inc. | A Award deriv | 2024-03-25 | 2024-03-27 | 700,000 | — | $0 | 700,000 | SEC↗ |
| EPIX ESSA Pharma Inc. | A Award deriv | 2024-03-25 | 2024-03-28 | 50,000 | — | $0 | 50,000 | SEC↗ |
| EVLO Evelo Biosciences, Inc. | S Sale | 2023-11-08 | 2023-11-08 | 1,811 | $0.33 | $598 | 22,259 | SEC↗ |
| EVLO Evelo Biosciences, Inc. | M Exercise deriv | 2023-11-07 | 2023-11-08 | 6,500 | — | $0 | 6,500 | SEC↗ |
| EVLO Evelo Biosciences, Inc. | M Exercise | 2023-11-07 | 2023-11-08 | 6,500 | — | $0 | 24,070 | SEC↗ |
| EVLO Evelo Biosciences, Inc. | S Sale | 2023-11-02 | 2023-11-03 | 3,999 | $0.33 | $1.3K | 17,570 | SEC↗ |
| EVLO Evelo Biosciences, Inc. | M Exercise deriv | 2023-11-01 | 2023-11-03 | 12,500 | — | $0 | 25,000 | SEC↗ |
| EVLO Evelo Biosciences, Inc. | M Exercise | 2023-11-01 | 2023-11-03 | 12,500 | — | $0 | 21,569 | SEC↗ |
| EVLO Evelo Biosciences, Inc. | A Award deriv | 2023-09-11 | 2023-09-13 | 37,500 | — | $0 | 37,500 | SEC↗ |
| EVLO Evelo Biosciences, Inc. | S Sale | 2023-08-08 | 2023-08-09 | 2,004 | $9.51 | $19.1K | 9,069 | SEC↗ |
| EVLO Evelo Biosciences, Inc. | M Exercise deriv | 2023-08-07 | 2023-08-09 | 6,500 | — | $0 | 13,000 | SEC↗ |
| EVLO Evelo Biosciences, Inc. | M Exercise | 2023-08-07 | 2023-08-09 | 6,500 | — | $0 | 11,073 | SEC↗ |
| EVLO Evelo Biosciences, Inc. | S Sale | 2023-05-08 | 2023-05-10 | 38,531 | $0.13 | $5.0K | 91,469 | SEC↗ |
| EVLO Evelo Biosciences, Inc. | M Exercise deriv | 2023-05-07 | 2023-05-09 | 130,000 | — | $0 | 390,000 | SEC↗ |
| EVLO Evelo Biosciences, Inc. | M Exercise | 2023-05-07 | 2023-05-09 | 130,000 | — | $0 | 130,000 | SEC↗ |
| EVLO Evelo Biosciences, Inc. | A Award deriv | 2023-02-07 | 2023-02-09 | 520,000 | — | $0 | 520,000 | SEC↗ |
| VLON Vallon Pharmaceuticals, In | J Other | 2022-12-13 | 2022-12-15 | 28,517 | — | $0 | 9,506 | SEC↗ |
| EVLO Evelo Biosciences, Inc. | A Award deriv | 2022-09-01 | 2022-09-01 | 440,000 | — | $0 | 440,000 | SEC↗ |
| VLON Vallon Pharmaceuticals, In | A Award | 2022-07-01 | 2022-07-06 | 38,023 | — | $0 | 38,023 | SEC↗ |
| EPIX ESSA Pharma Inc. | A Award deriv | 2022-06-29 | 2022-11-01 | 22,500 | — | $0 | 22,500 | SEC↗ |
| VLON Vallon Pharmaceuticals, In | A Award deriv | 2022-06-09 | 2022-06-10 | 7,500 | — | $0 | 7,500 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | J Other | 2022-03-21 | 2022-03-23 | 52,101 | — | $0 | 53,101 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | A Award deriv | 2022-02-01 | 2022-02-03 | 67,500 | — | $0 | 67,500 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | P Buy | 2021-06-02 | 2021-06-04 | 1,000 | $20.00 | $20.0K | 1,000 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | A Award deriv | 2021-05-27 | 2021-06-01 | 137,500 | — | $0 | 137,500 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | A Award deriv | 2021-02-19 | 2021-06-01 | 208,474 | — | $0 | 208,474 | SEC↗ |
| VLON Vallon Pharmaceuticals, In | A Award deriv | 2021-02-12 | 2021-02-12 | 15,000 | — | $0 | 15,000 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | A Award deriv | 2021-01-29 | 2021-06-01 | 9,487 | — | $0 | 9,487 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | A Award deriv | 2021-01-29 | 2021-06-01 | 58,956 | — | $0 | 58,956 | SEC↗ |
| EPIX ESSA Pharma Inc. | A Award deriv | 2020-12-11 | 2021-01-11 | 16,500 | — | $0 | 16,500 | SEC↗ |
| EPIX ESSA Pharma Inc. | A Award deriv | 2020-12-11 | 2021-01-26 | 16,500 | — | $0 | 16,500 | SEC↗ |